Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Venetoclax restores normal apoptosis of cancer cells by blocking the anti-apopto···【more】
Release date：2024-08-14Recommended：571
Venetoclax is the only approved inhibitor of Bcl-2, which achieves high selectiv···【more】
Release date：2024-08-14Recommended：544
Venetoclax is an oral, small-molecule targeted drug that restores the apoptosis ···【more】
Release date：2024-08-14Recommended：503
Venetoclax is the world's first approved selective inhibitor of Bcl-2 that i···【more】
Release date：2024-08-14Recommended：541
Pemigatinib is a targeted therapy drug that is of great significance in the trea···【more】
Release date：2024-08-14Recommended：455
Pemigatinibis primarily used for the treatment of adult patients with advanced, ···【more】
Release date：2024-08-14Recommended：478
Pemigatinibhas demonstrated significant efficacy in the treatment of cholangioca···【more】
Release date：2024-08-14Recommended：478
Pemigatinib is used in adults to treat bile duct cancer that has spread to other···【more】
Release date：2024-08-14Recommended：469
Pemigatinib is an effective treatment for advanced or metastatic cholangiocarcin···【more】
Release date：2024-08-14Recommended：468
Pemigatinib leads to constitutive activation of FGFR by activating FGFR amplific···【more】
Release date：2024-08-14Recommended：464
Venetoclax is a targeted anti-cancer drug used to treat certain types of blood c···【more】
Release date：2024-08-13Recommended：517
Venetoclax is a novel oral small molecule drug that targets the BCL-2 protein to···【more】
Release date：2024-08-13Recommended：632
Telegram name: Vira
Name: LUCIUS
No.:0085253923643
